易方达标普生物科技美元现汇C(012867)

动态评分: 6.13分

投资组合

报告日期 名称 比例
2024-12-31 CRISPR Therapeutics AG 1.09%
2024-12-31 阿尔凯默斯 1.01%
2024-12-31 Summit Therapeutics Inc 0.93%
2024-12-31 Arcellx Inc 0.91%
2024-12-31 Avidity Biosciences Inc 0.86%
2024-12-31 Biohaven Ltd 0.84%
2024-12-31 Nuvalent Inc-A 0.77%
2024-12-31 SpringWorks Therapeutics Inc 0.74%
2024-12-31 Twist Bioscience Corp 0.72%
2024-12-31 Krystal Biotech Inc 0.71%
2024-12-31 Ultragenyx Pharmaceutical Inc 0.71%
2024-12-31 杰龙 0.71%
2024-12-31 Iovance Biotherapeutics Inc 0.69%
2024-12-31 Crinetics Pharmaceuticals Inc 0.69%
2024-12-31 Recursion Pharmaceuticals Inc-A 0.67%
2024-12-31 Dyne Therapeutics Inc 0.66%
2024-12-31 塞德斯医疗 0.64%
2024-12-31 Vera Therapeutics Inc-A 0.62%
2024-12-31 Protagonist Therapeutics Inc 0.61%
2024-12-31 Veracyte Inc 0.59%

投资模拟

公告&资料